William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 6,706 shares at $25.45 ($171K) on 2024-11-20, disclosed to the SEC on 2024-11-22.
Open-market sale of $171k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.45 | 3,353 | $85K | 50.0% |
| 2 | $25.45 | 3,353 | $85K | 50.0% |
| Total | $25.45 avg | 6,706 | $171K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |
| IMVT | SELL | 2024-07-19 | $160K | — | Filing → |